"Would You Get a Destination Therapy Left Ventricular Assist Device?": Health Care Workers' Views on a Preference-Sensitive Decision
- PMID: 36062460
- PMCID: PMC9771860
- DOI: 10.1161/CIRCHEARTFAILURE.122.009626
"Would You Get a Destination Therapy Left Ventricular Assist Device?": Health Care Workers' Views on a Preference-Sensitive Decision
Conflict of interest statement
Financial Conflict of Interest / Disclosures
Dr. Allen reports grant funding from AHA, NIH, and PCORI; and consulting fees from Abbott, ACI Clinical, Amgen, Boston Scientific, Cytokinetics, and Novartis. Dr. Matlock has received funding from the NIH, American College of Cardiology Foundation, and PCORI. Remaining authors report no significant conflicts.
References
-
- McIlvennan CK, Allen LA, Nowels C, Brieke A, Cleveland JC, Matlock DD. Decision making for destination therapy left ventricular assist devices: “there was no choice” versus “I thought about it an awful lot”. Circ Cardiovasc Qual Outcomes. 2014. May;7(3):374–80. doi: 10.1161/CIRCOUTCOMES.113.000729. Epub 2014 May 13. - DOI - PMC - PubMed
-
- Thompson JS, Fitzgerald MD, Allen LA, McIlvennan CK, Glasgow RE, Wynia M, Morris MA, Beilenson J, Gherst C, Matlock DD. Shared Decision-Making for Left Ventricular Assist Devices: Rationale and Design of a Nationwide Dissemination and Implementation Project. Circ Cardiovasc Qual Outcomes. 2021. Feb;14(2):e007256. doi: 10.1161/CIRCOUTCOMES.120.007256. Epub 2021 Feb 3. - DOI - PMC - PubMed
-
- Demyan L, Siskind S, Harmon L, Ramirez CL, Bank MA, Dela Cruz RA, Giangola MD, Patel VM, Scalea TM, Stein DM, Botwinick I. Do It to Them, Not to Me: Doctors’ and Nurses’ Personal Preferences Versus Recommendations for End-of-Life Care. J Surg Res. 2021. Aug;264:76–80. doi: 10.1016/j.jss.2021.01.036. Epub 2021 Mar 29. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical